| IdentiClone™ Gene Clonality Assays |
IdentiClone™ Gene Translocation Assays | LeukoStrat™ Gene Mutation Assays | ||
|
IdentiClone Gene Clonality Assays were developed and clinically validated by the BIOMED-2 Group. They are in vitro diagnostic products intended for PCR-based detection of clonal gene rearrangements in patients with suspect lymphoproliferations. These standardized PCR-based tests include a Standard Operating Procedure (SOP), an interpretative guide, master mixes, and controls.
Master Mixes
Multiple Primers
Assay Kits
IGH Gene Clonality Assays |
IdentiClone Gene Translocation Assays were developed and clinically validated by the BIOMED-2 Group. They are in vitro diagnostic products intended for PCR-based detection of gene translocations in patients with suspect lymphoproliferations. These standardized PCR-based tests include a Standard Operating Procedure (SOP), an interpretative guide, master mixes, and controls.
Master Mixes
Multiple Primers
Assay Kits
BCL1/JH t(11;14) Translocation Assays |
LeukoStrat Gene Mutation Assays are in vitro diagnostic products intended for PCR-based detection of gene mutations in patients with acute myeloid leukemia (AML) and other lymphoproliferative diseases. These standardized PCR-based tests include a Standard Operating Procedure (SOP), an interpretative guide, master mixes, and controls.
Master Mixes
Assay Kits |
The following trademarks are owned by Invivoscribe Technologies, Inc.: IdentiClone™, LeukoStrat™, LymphoTrack™, PurePlus™, Personalized Molecular Diagnostics™, Personalized Molecular Medicine™